Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.

Antimicrobial agents and chemotherapy - 1 Sept 1999

Fines M, Perichon B, Reynolds P, Sahm D F, Courvalin P

Abstract excerpt

Enterococcus faecalis BM4405 was resistant to low levels of vancomycin (MIC, 16 microg/ml) and was susceptible to teicoplanin (MIC, 0.5 microg/ml). No PCR product was obtained when the total DNA of this clinical isolate was used as a template with primers specific for glycopeptide resistance genes vanA, vanB, vanC, and vanD. However, a 604-bp PCR fragment was obtained when V1 and V2 degenerate primers were used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-Bacterial Agents
Share to Drug Resistance, Microbial

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enterococcus faecalis

Share to Microbial Sensitivity Tests

Share to Peptidoglycan

Share to Racemases and Epimerases

Share to Teicoplanin

Share to Vancomycin

Source

Open in PubMed Open full text

Identifiers

PMID: 10471558
DOI: 10.1128/AAC.43.9.2161
PMCID: PMC89440

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405.PMID 10471558Read ↗

VanD-type glycopeptide-resistant Enterococcus faecium BM4339.Semantic proximity Read ↗

Silencing of glycopeptide resistance in Enterococcus faecalis BM4405 by novobiocin.Semantic proximity Read ↗

Epidemiology of the genetic elements responsible for acquired glycopeptide resistance in enterococci.Semantic proximity Read ↗

Acquired Vancomycin Resistance in Clinically Relevant PathogensSemantic proximity Read ↗

Genetic characterization of a VanG-type vancomycin-resistant Enterococcus faecium clinical isolate.Semantic proximity Read ↗

Characterization of a divergent vanD-type resistance element from the first glycopeptide-resistant strain of Enterococcus faecium isolated in Brazil.Semantic proximity Read ↗

Genetic description of VanD phenotype vanA genotype in vancomycin-resistant Enterococcus faecium isolates from a Bone Marrow Transplantation Unit.Semantic proximity Read ↗

<i>vanM</i> , a New Glycopeptide Resistance Gene Cluster Found in <i>Enterococcus faecium</i>Semantic proximity Read ↗

VanD-Type Vancomycin-Resistant Enterococcus faecium and Enterococcus faecalisSemantic proximity Read ↗

Detection of an unusual van genotype in a vancomycin-resistant Enterococcus faecium hospital isolate.Semantic proximity Read ↗

Tandem amplification of the vanM gene cluster drives vancomycin resistance in vancomycin-variable enterococciSemantic proximity Read ↗

Vancomycin-resistant enterococci.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.